Evidence map›Paper›PMID 30249477›Full record

ArticleMutation research. Genetic toxicology and environmental mutagenesis2018

DNA damaging agents trigger the expression of the HML silent mating type locus in Saccharomyces cerevisiae.

Michael Derevensky, Michael Fasullo

Abstract read
In one paragraph

Article in Mutation research. Genetic toxicology and environmental mutagenesis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. A Strategy for the Rapid Development of a SafeInternational journal of molecular sciences · 2021
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael DerevenskyCollege of Nanoscale Sciences and Engineering, SUNY Polytechnic Institute, 257 Fuller Road, Albany, NY 12205, United States.
Michael FasulloCollege of Nanoscale Sciences and Engineering, SUNY Polytechnic Institute, 257 Fuller Road, Albany, NY 12205, United States. Electronic address: mfasullo@sunypoly.edu.
SUNY Polytechnic Institute · US

Funding

Genomic profiling of yeast resistance to heterocylic aromatic aminesR15ES023685 · NIEHS · SUNY POLYTECHNIC INSTITUTE · PI FASULLO, MICHAEL THOMAS · 2014 to 2019
$903k
NIEHS NIH HHS R15 ES023685
6 · The paper itself

Abstract

Many DNA damaging agents also react with RNA and protein, and could thus cause epigenetic as well as genotoxic changes. To investigate which DNA damaging agents alter epigenetic states, we studied the chemical-induced changes in expression of the yeast silent mating type locus HMLα, which can be triggered by inhibiting yeast Sir2. We observed that the alkylating agent methyl methane sulfonate (MMS) can result in HMLα expression, using a colony sector assay that results from expression of a HML-positioned cre gene. Using single-cell imaging we also observed that alkylating agents, including MMS and methyl-3-nitro-1-nitrosoguanidine (MNNG), as well as short-wave UV, also decreased HML silencing. We suggest that chemical-induced alterations in heterochromatin structure could confer transient phenotypic changes that affect the cellular responses to DNA damaging agents.

Indexed as

Gene SilencingGenes, Mating Type, FungalDNA, FungalGene Expression Regulation, FungalHeterochromatinSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSulfinic AcidsDNA, FungalHeterochromatinmethyl methanethiosulfinateSaccharomyces cerevisiae ProteinsSulfinic AcidsBudding yeastDNA damaging agentEpigeneticsSir-mediated gene silencing

Identifiers

PMID30249477
PMCPMC6159220
OpenAlexW2888177104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.